Clinical trials
Lung Neoplasms trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
168 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2006 | 6 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 5 |
| 2010 | 4 |
| 2011 | 6 |
| 2012 | 3 |
| 2013 | 9 |
| 2014 | 4 |
| 2015 | 6 |
| 2016 | 5 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 10 |
| 2020 | 3 |
| 2021 | 8 |
| 2022 | 13 |
| 2023 | 13 |
| 2024 | 15 |
| 2025 | 12 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 83 |
| Recruiting | 36 |
| Active, not recruiting | 17 |
| Terminated | 15 |
| Unknown status | 10 |
| Withdrawn | 5 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 17 |
| Maastricht Radiation Oncology | 12 |
| Novartis Pharmaceuticals | 10 |
| Radboud University Medical Center | 8 |
| University Medical Center Groningen | 7 |
| The Netherlands Cancer Institute | 6 |
| AstraZeneca | 5 |
| Bristol-Myers Squibb | 5 |
| Amgen | 4 |
| Amsterdam UMC, location VUmc | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 168 |
| Carcinoma, Non-Small-Cell Lung | 72 |
| Neoplasms | 26 |
| Breast Neoplasms | 16 |
| Neoplasm Metastasis | 12 |
| Carcinoma | 11 |
| Lung Diseases | 11 |
| Stomach Neoplasms | 11 |
| Colorectal Neoplasms | 10 |
| Head and Neck Neoplasms | 10 |
Trials
Showing 76 to 100 of 168. Each trial links to its page on Pharma Observatory.
68 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.